- Home
- OPTX vs VTVT Comparison
OPTX vs VTVT Comparison
Compare OPTX & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPTX | VTVT |
|---|---|---|
| Founded | 1981 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 54.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | OPTX | VTVT |
|---|---|---|
| Price | $1.41 | $26.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $37.00 |
| AVG Volume (30 Days) | ★ 105.4K | 13.0K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,900,395.00 | $17,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.88 | $13.15 |
| 52 Week High | $5.10 | $33.16 |
Technical Indicators
Market Signals| Indicator | OPTX | VTVT |
|---|---|---|
| Relative Strength Index (RSI) | 37.49 | 52.96 |
| Support Level | $1.30 | $22.92 |
| Resistance Level | $1.49 | $32.53 |
| Average True Range (ATR) | 0.18 | 1.72 |
| MACD | -0.01 | -0.57 |
| Stochastic Oscillator | 25.00 | 43.27 |
Price Performance
Historical ComparisonAbout OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin, being investigated for the treatment of type 1 diabetes (T1D). Its product pipeline includes TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.